Twister, you tempted me to respond once more <ggg>.
When NH was at $9 and CSE was trading at $18+ (if I recall correctly),
a 2 1/2 for 1 share deal for CSE would have had analysts falling all over themselves saying what a good deal NH got, a modest premium, synergies, a larger more stable company, at least the same if not higher projected EPS, solid balance sheet, etc. It does not change a bit if this happens when NH has doubled if you pay in stock.
However, if when NH was $9 and CSE $18+, NH offered $55 cash, the analysts would have fallen all over themselves saying what complete idiots NH was, blah, blah, blah. It only changes very slightly if this happens when NH and CSE have risen dramatically (relating to possible future NH equity offerings at better prices to reduce the debt).
Enough said.
|
